Alignment Healthcare Reports Third Quarter 2026 Results, Updates Full-Year Outlook

Alignment Healthcare, Inc. (ALHC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 Alignment Healthcare Reports Third Quarter 2026 Results, Updates Full-Year Outlook Reports third-quarter revenue of $ 1.36 billion, representing 36.7% year-over-year growth Grows health plan membership 31.2% year-over-year to 301,200 members Issues fourth-quarter gui

Event · Earnings
Also in this documentGuidance · raise · 305K

Facts are quoted from the filing text and checked against it.

Original reporting
Published Oct 29, 2026, 8:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 8:03 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$ALHC
Bearish
high confidence
Mentioned
$ALHC
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$ALHCBearishMed
01

Why it matters

the lowered profit guidance may trigger a short‑term sell‑off, but strong membership growth offers a longer‑term upside narrative.

02

Market read

the earnings release provides fresh guidance that can move the stock and influences peers in the Medicare Advantage space.

03

What to watch

the 31% membership increase could drive longer‑term revenue upside despite short‑term profit compression

Relevance 7/10Novelty 7/10Timing: pre‑market today
AlphAI · Earnings readALHC · Third Quarter 2026 · ended Sept. 30, 2026

Alignment Healthcare Reports Third Quarter 2026 Results, Updates Full-Year Outlook

→Mixed quarter

Revenue and membership grew 36.7% and 31.2% year-over-year, respectively, but higher medical costs drove a 32.8% decline in adjusted EBITDA, a net loss of $8.1 million, and lower full-year adjusted gross profit and adjusted EBITDA guidance.

Revenue
$1.36B
up 36.7% year-over-year y/y
EPS · GAAP
(0.04)
Three Months Ending December 31, 2026 and Twelve Months Ending December 31, 2026 outlook
$1,316 for three months ending December 31, 2026; $5,245 for twelve months ending December 31, 2026

Actuals vs. the company’s prior outlook

from its previous release
MetricGuidedReportedVerdict
Revenue, Q3$1,300 to $1,320$ 1,358,290 (in thousands)above
Adjusted gross profit, Q3$148 to $158$ 142,205 (in thousands)below

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Health plan membership at end of quarterotherapproximately 301,200–up 31.2% year-over-year
Total revenues, three months ended September 30, 2026GAAP$1.36B–up 36.7% year-over-year
Earned premiums, three months ended September 30, 2026GAAP$1.35B––
Other revenue, three months ended September 30, 2026GAAP$10.03M––
Medical expenses, three months ended September 30, 2026GAAP$1.22B––
Medical benefits ratio, three months ended September 30, 2026non-GAAP89.5%–an increase of approximately 240 basis points year-over-year
Selling, general, and administrative expenses, three months ended September 30, 2026GAAP$136.4M––
Depreciation and amortization, three months ended September 30, 2026GAAP$8.11M––
Total expenses, three months ended September 30, 2026GAAP$1.36B––
Loss from operations, three months ended September 30, 2026GAAP−$3.79M––
Adjusted gross profit, three months ended September 30, 2026non-GAAP$142.2M–up 11.6% year-over-year
Interest expense, three months ended September 30, 2026GAAP$4.28M––
Income (loss) before income taxes, three months ended September 30, 2026GAAP−$8.07M––
Provision (benefit) for income taxes, three months ended September 30, 2026GAAP−$22K––
Net income (loss), three months ended September 30, 2026GAAP−$8.05M––
Net income (loss) attributable to Alignment Healthcare, Inc., three months ended September 30, 2026GAAP−$8.05M––
Basic net income (loss) per share attributable to Alignment Healthcare, Inc., three months ended September 30, 2026GAAP(0.04)––
Diluted net income (loss) per share attributable to Alignment Healthcare, Inc., three months ended September 30, 2026GAAP(0.04)––
Adjusted EBITDA, three months ended September 30, 2026non-GAAP$21.81M–declined 32.8% year-over-year
Adjusted EBITDA margin, three months ended September 30, 2026non-GAAP1.6%––
Total revenues, nine months ended September 30, 2026GAAP$3.93B––
Earned premiums, nine months ended September 30, 2026GAAP$3.90B––
Other revenue, nine months ended September 30, 2026GAAP$27.67M––
Medical expenses, nine months ended September 30, 2026GAAP$3.46B––
Selling, general, and administrative expenses, nine months ended September 30, 2026GAAP$388.5M––
Depreciation and amortization, nine months ended September 30, 2026GAAP$23.80M––
Total expenses, nine months ended September 30, 2026GAAP$3.88B––
Income from operations, nine months ended September 30, 2026GAAP$53.81M––
Adjusted gross profit, nine months ended September 30, 2026non-GAAP$471.0M––
Net income, nine months ended September 30, 2026GAAP$39.92M––
Net income attributable to Alignment Healthcare, Inc., nine months ended September 30, 2026GAAP$39.92M––
Basic net income per share attributable to Alignment Healthcare, Inc., nine months ended September 30, 2026GAAP0.19––
Diluted net income per share attributable to Alignment Healthcare, Inc., nine months ended September 30, 2026GAAP0.19––
Adjusted EBITDA, nine months ended September 30, 2026non-GAAP$127.8M––

Amounts quoted below without a unit are in thousands, as in the filing’s tables. Per-share figures are as printed.

Three Months Ending December 31, 2026 and Twelve Months Ending December 31, 2026 outlook

  • Revenue$1,316 for three months ending December 31, 2026; $5,245 for twelve months ending December 31, 2026
  • NoteHealth Plan Membership: no less than 305,000 for three months ending December 31, 2026; no less than 305,000 for twelve months ending December 31, 2026
  • NoteAdjusted Gross Profit: $104 for three months ending December 31, 2026; $575 for twelve months ending December 31, 2026
  • NoteAdjusted EBITDA: $(28) for three months ending December 31, 2026; $100 for twelve months ending December 31, 2026

What drove it

  • Health plan membership was approximately 301,200, up 31.2% year-over-year.
  • Total revenue was $1,358.3 million, up 36.7% year-over-year.
  • Full-year health plan membership and revenue guidance was raised to reflect continued sales momentum.
  • Medical benefits ratio reflected previously expected changes in Part D seasonality and timing of clinical investments.

Concerns

  • Medical trends ran higher than expected.
  • The medical benefits ratio was 89.5%, an increase of approximately 240 basis points year-over-year.
  • The company cited higher costs from elevated appeals and disputes and increased costs within catastrophic cases and skilled nursing categories.
  • Full-year adjusted gross profit and adjusted EBITDA guidance was lowered to reflect higher medical costs experienced during the third quarter.
  • The third quarter recorded a loss from operations of $3.8 million and net loss of $8.1 million.

What to watch

  • Execution against actions underway, which revised guidance does not assume will provide any benefit.
  • Fourth-quarter medical-cost trends, including appeals and disputes, catastrophic cases, and skilled nursing categories.
  • Health plan membership against guidance of no less than 305,000.
  • Fourth-quarter adjusted gross profit guidance of $104 and adjusted EBITDA guidance of $(28).
  • Full-year adjusted gross profit guidance of $575 and adjusted EBITDA guidance of $100.

Balance sheet and cash flow

  • Cash and cash equivalents as of September 30, 2026: $ 727,694; December 31, 2025: $ 575,817
  • Investments - current as of September 30, 2026: 15,260; December 31, 2025: 28,413
  • Total assets as of September 30, 2026: $ 1,296,863; December 31, 2025: $ 1,065,786
  • Medical expenses payable as of September 30, 2026: $ 621,746; December 31, 2025: $ 474,569
  • Long-term debt, net of debt issuance costs, as of September 30, 2026: 324,497; December 31, 2025: 323,176
  • Total liabilities as of September 30, 2026: 1,019,751; December 31, 2025: 886,509
  • Total stockholders' equity as of September 30, 2026: 277,112; December 31, 2025: 179,277
  • Net cash provided by operating activities, nine months ended September 30, 2026: 158,395; 2025: 190,302
  • Acquisition of property and equipment, nine months ended September 30, 2026: (25,952); 2025: (21,752)
  • Net cash used in investing activities, nine months ended September 30, 2026: (12,327); 2025: (7,811)
  • Net cash provided by financing activities, nine months ended September 30, 2026: 5,834; 2025: 2,745
  • Net increase in cash, nine months ended September 30, 2026: 151,902; 2025: 185,236
  • Cash, cash equivalents and restricted cash at end of period, September 30, 2026: $ 729,839; September 30, 2025: $ 620,178

Analysis

Alignment reported third-quarter total revenue of $1,358.3 million, up 36.7% year-over-year, while health plan membership reached approximately 301,200, up 31.2% year-over-year. The company characterized the membership and revenue results as evidence of continued demand, and raised full-year health plan membership and revenue guidance to reflect continued sales momentum.

Profitability lagged the top-line expansion. Adjusted gross profit increased 11.6% year-over-year to $142.2 million, while the medical benefits ratio was 89.5%, an increase of approximately 240 basis points year-over-year. Management attributed the result to expected Part D seasonality and clinical-investment timing, alongside higher costs from elevated appeals and disputes and increased catastrophic-case and skilled-nursing costs.

The cost pressure moved quarterly GAAP results into loss territory. Loss from operations was $3.8 million compared with income from operations of $7.7 million in the prior-year quarter, and net loss was $8.1 million compared with net income of $3.7 million. Adjusted EBITDA declined 32.8% year-over-year to $21.8 million, with an adjusted EBITDA margin of 1.6%.

The balance sheet showed $727.7 million of cash and cash equivalents and $324.5 million of long-term debt, net of debt issuance costs, at September 30, 2026. Net cash provided by operating activities for the nine months ended September 30, 2026 was $158.4 million, compared with $190.3 million in the prior-year period. The release reported no capital-return activity.

For the fourth quarter, the company guided to revenue of $1,316, adjusted gross profit of $104, and adjusted EBITDA of $(28). Full-year guidance calls for revenue of $5,245, adjusted gross profit of $575, and adjusted EBITDA of $100, with health plan membership of no less than 305,000. The company lowered its adjusted gross profit and adjusted EBITDA outlook based on third-quarter medical costs and stated that revised guidance assumes no benefit from actions underway.

Management, verbatim

Our third-quarter membership and revenue growth demonstrate continued demand for Alignment’s products and services, while medical trends ran higher than expected.

John Kao, chairman and CEO

We are taking a prudent approach to the fourth quarter and lowering our outlook based on current headwinds.

John Kao, chairman and CEO

Our revised guidance does not assume any benefit from the actions underway.

John Kao, chairman and CEO

Not in the filing

stated, not guessed
  • GAAP gross margin was not reported.
  • Prior-quarter comparisons were not reported for the disclosed operating metrics.
  • No reportable revenue segments or segment-level results were provided.
  • Free cash flow was not reported.
  • Share repurchases, dividends, and other capital-return activity were not reported.
  • Fourth-quarter and full-year guidance for operating expenses and tax rate was not reported.
  • GAAP EPS guidance was not reported.

Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. Guided figures in the outlook comparison come from the company’s previous release. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Background

Alignment Healthcare filed a Form 8‑K reporting Q3 2026 results and updating its FY outlook.

Company-level read

Ticker impact

$ALHCBearishHigh confidence
Context

the company lowered guidance for adjusted gross profit and adjusted EBITDA for FY 2026

Expected impact

likely downside pressure as investors price in weaker profitability

Evidence & confidence

the 8‑K shows a 32.8% YoY decline in adjusted EBITDA and a cut to profit guidance, which typically triggers sell‑side sentiment

Market effects

signals potential margin pressure for other Medicare Advantage providers

U.S. health‑care sector may see modest pullback

limited to U.S. health‑care equities

Counterpoint

if the membership growth continues, the profit dip could be temporary and the stock may rebound

Key entities

  • Alignment Healthcare, Inc.

    NASDAQ‑listed senior‑care provider

Every ALHC earnings report

This story covers one filing. The ticker page keeps them all: each quarter's reported metrics with year-over-year and sequential comparisons, segments, guidance, and how the numbers landed against the company's own prior outlook.

Related articles

$ALHCMedAI 8/10

Alignment Healthcare (ALHC) Q3 2026 Earnings Call Transcript

Alignment Healthcare (ALHC) reported Q3 2026 earnings, with revenue of $1.4B (up 37% YoY) and adjusted gross profit of $142M. The company lowered annual guidance due to higher costs, targeting adjusted gross profit of at least $575M and adjusted EBITDA of $100M. Membership grew 31% YoY to 301,200. ALHC is addressing cost pressures and investing in clinical programs for 2027 growth.

$ALHCMedAI 8/10

What Alignment Healthcare (ALHC) Said on Its Q3 Earnings Call

Alignment Healthcare (ALHC) reduced its 2026 outlook, expecting at least $5.25B revenue, $575M adjusted gross profit, and $100M adjusted EBITDA. Q4 forecasts include 305K membership, $1.32B revenue, and $104M gross profit. Management targets 20% top-line growth in 2027, with plans to enter new markets and improve care model scalability. Stars ratings and provider alignment remain focus areas.